AnalystsDoug SchenkelDoug Schenkel's Stock Forecasts
AnalystsDoug Schenkel
Analyst Ranking
Bottom 14%
#4239 out of 4867 analysts
Average Return
-1.69%
Win Rate
42%15 out of 36
Risk vs Reward
Poor
Good
Doug Schenkel's 5 best and worst ratings
| Name / Ticker | Gain/Loss | Entry Price | Exit Price | Period | Rating |
|---|---|---|---|---|---|
Natera IncNTRA | +231.00% | $32.13 | $106.35 | 2020-04-15 - 2021-04-15 | Buy |
Dexcom IncDXCM | +214.79% | $11.36 | $35.76 | 2017-09-28 - 2018-09-28 | Buy |
Exact Sciences CorpEXAS | +81.43% | $22.99 | $41.71 | 2017-03-27 - 2018-03-27 | Buy |
Exact Sciences CorpEXAS | +72.59% | $30.14 | $52.02 | 2017-04-27 - 2018-04-27 | Buy |
Dexcom IncDXCM | +55.67% | $14.02 | $21.82 | 2014-12-08 - 2015-12-08 | Buy |
Doug Schenkel Analyst Color
Get additional color on Doug Schenkel's coverage of popular stocks
Doug Schenkel's Stock Coverage
| Name / Ticker | No. Ratings | Rating | Price Target | Upside/Downside | Action | Date |
|---|---|---|---|---|---|---|
Tempus Ai IncTEM | 1 | Buy | $60.00 | +11.59% | Initiates Coverage On | 5 months ago |
Twist Bioscience CorpTWST | 2 | Buy | $60.00 | +50.38% | Initiates Coverage On | 5 months ago |
Stevanato Group SpaSTVN | 1 | Buy | $28.00 | +29.75% | Initiates Coverage On | 5 months ago |
Danaher CorpDHR | 1 | Buy | $285.00 | +45.47% | Upgrades | 6 months ago |
Qiagen NvQGEN | 1 | Buy | $50.00 | +17.73% | Upgrades | 10 months ago |
Thermo Fisher Scientific IncTMO | 2 | Buy | $655.00 | N/A | Maintains | 4 years ago |
Agilent Technologies IncA | 2 | Buy | $200.00 | N/A | Maintains | 4 years ago |
Sophia Genetics SaSOPH | 1 | Buy | N/A | N/A | Initiates Coverage On | 4 years ago |
Absci CorpABSI | 1 | Hold | N/A | N/A | Initiates Coverage On | 4 years ago |
Sera Prognostics IncSERA | 1 | Buy | N/A | N/A | Initiates Coverage On | 4 years ago |
Zymergen IncZY | 1 | Hold | N/A | N/A | Downgrades | 4 years ago |
Telesis Bio IncTBIO | 1 | Buy | N/A | N/A | Initiates Coverage On | 4 years ago |
Singular Genomics Systems IncOMIC | 1 | Buy | N/A | N/A | Initiates Coverage On | 4 years ago |
Genmark Diagnostics IncGNMK | 1 | Hold | $24.05 | N/A | Downgrades | 4 years ago |
Guardant Health IncGH | 1 | Buy | $190.00 | N/A | Maintains | 4 years ago |
10x Genomics IncTXG | 1 | Buy | $200.00 | N/A | Maintains | 4 years ago |
Exact Sciences CorpEXAS | 3 | Buy | $180.00 | N/A | Maintains | 4 years ago |
908 Devices IncMASS | 1 | Buy | N/A | N/A | Initiates Coverage On | 4 years ago |
Nanostring Technologies IncNSTGQ | 2 | Buy | $75.00 | N/A | Upgrades | 4 years ago |
Amyris IncAMRSQ | 4 | Buy | $9.00 | N/A | Upgrades | 4 years ago |
Seer IncSEER | 1 | Buy | N/A | N/A | Initiates Coverage On | 4 years ago |
Burning Rock Biotech LtdBNR | 1 | Buy | N/A | N/A | Initiates Coverage On | 5 years ago |
Hologic IncHOLX | 3 | Buy | $64.00 | N/A | Upgrades | 5 years ago |
Natera IncNTRA | 1 | Buy | $40.00 | N/A | Maintains | 5 years ago |
Illumina IncILMN | 1 | Buy | $335.00 | N/A | Maintains | 5 years ago |
Codexis IncCDXS | 1 | Buy | $18.00 | N/A | Initiates Coverage On | 7 years ago |
Insulet CorpPODD | 1 | Buy | $90.00 | N/A | Maintains | 7 years ago |
Quanterix CorpQTRX | 1 | Buy | N/A | N/A | Initiates Coverage On | 7 years ago |
Check Point Software Technologies LtdCHKP | 1 | Hold | N/A | N/A | Downgrades | 7 years ago |
Dexcom IncDXCM | 2 | Buy | $16.00 | N/A | Maintains | 8 years ago |
Oxford Immunotec Global PLCOXFD | 1 | Buy | $19.00 | N/A | Maintains | 8 years ago |
Genomic Health IncGHDX | 1 | Hold | N/A | N/A | Downgrades | 8 years ago |
Tandem Diabetes Care IncTNDM | 1 | Buy | $160.00 | N/A | Initiates Coverage On | 10 years ago |
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletterWallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.